TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff. October 21, 2005
TCL Archive Diet-Nutrition Grant Guidelines: NIH Says They’re CREGS, Gori Says They’re Not April 9, 1976
TCL Archive Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach. July 9, 2004
TCL Archive Plans For NIH Women’s Health Study Discussed In Forum; $500 Mil. Program To Be Funded Through Contracts November 8, 1991
TCL Archive ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board” January 25, 1985
